XML 49 R33.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information (Tables)
 6 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following tables present revenue for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended December 31,
(in millions)20242023
Pharmaceutical and Specialty Solutions$50,849 $53,202 
Global Medical Products and Distribution3,154 3,127 
Nuclear and Precision Health Solutions372 330 
at-Home Solutions
835 739 
OptiFreight® Logistics
76 66 
Other
1,283 1,135 
Total segment revenue55,286 57,464 
Corporate (1)
(22)(22)
Total revenue$55,264 $57,442 

Six Months Ended December 31,
(in millions)20242023
Pharmaceutical and Specialty Solutions$98,839 $103,790 
Global Medical Products and Distribution6,277 6,159 
Nuclear and Precision Health Solutions745 654 
at-Home Solutions
1,574 1,406 
OptiFreight® Logistics
150 126 
Other
2,469 2,186 
Total segment revenue107,585 112,135 
Corporate (1)
(44)(43)
Total revenue$107,541 $112,092 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following tables present revenue by geographic area:
Three Months Ended December 31,
(in millions)20242023
United States$54,858 $57,049 
International428 415 
 Total segment revenue55,286 57,464 
Corporate (1)(22)(22)
Total revenue$55,264 $57,442 
Six Months Ended December 31,
(in millions)20242023
United States$106,749 $111,319 
International836 816 
Total segment revenue107,585 112,135 
Corporate (1)(44)(43)
Total revenue$107,541 $112,092 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended December 31,
(in millions)20242023
Pharmaceutical and Specialty Solutions
$531 $495 
Global Medical Products and Distribution
18 11 
Other (1)118 106 
Total segment profit667 612 
Corporate(118)(107)
Total operating earnings
$549 $505 

Six Months Ended December 31,
(in millions)20242023
Pharmaceutical and Specialty Solutions
$1,061 $951 
Global Medical Products and Distribution
26 23 
Other (1)222 202 
Total segment profit1,309 1,176 
Corporate(192)(703)
Total operating earnings
$1,117 $473 
(1)Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.
Assets by Reportable Segment
The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)December 31,
2024		June 30,
2024
Pharmaceutical and Specialty Solutions
$32,125 $29,149 
Global Medical Products and Distribution
7,055 7,047 
Other
2,720 2,606 
Corporate 5,102 6,319 
Total assets$47,002 $45,121